Packaging & Labelling
Packaging & Labelling
ILC Dover takes over Grayling Industries
ILC Dover has purchased Grayling Industries, a provider of advanced industrial packaging for pharmaceutical dry powder and liquid applications, food and chemicals. Grayling is involved in manufacturing various brands for the asbestos abatement and...
Packaging & Labelling
Walmart pharmacies offer Ecoslide-RX prescription pharmaceutical package
Walmart pharmacies has announced the availability of Ecoslide-RX, an eco-friendly prescription pharmaceutical package which is said to be designed to improve patients' adherence to medications. The package, which is manufactured by Keystone Folding Box...
Packaging & Labelling
Avery Dennison releases new anti-counterfeiting technology
Avery Dennison has unveiled a new anti-counterfeiting technology, Sharp Tear that enables existing serial numbers to be read directly through the label. The new technology with thin and clear co-extruded film will provide an...
Packaging & Labelling
Dynaflex to provide packaging services to pharma industry
India-based packaging products producer, Dynaflex is planning to provide packaging services to the pharmaceuticals industry. Dynaflex director Gaurav Vora was quoted by Business Standard as saying that the company sees potential in the pharma...
Packaging & Labelling
Bosch Packaging opens new manufacturing facility in India
Bosch Packaging Technology, a supplier of process and packaging technology, has opened a new 34 crores (€5m) manufacturing facility in Verna, Goa, India. The 33,000ft² facility is designed to fulfill capacity expansion and meet...
Packaging & Labelling
Schreiner unveils color laser film label for dental carpules
Schreiner MediPharm, a Germany-based provider of specialty pharmaceutical labeling solutions, has introduced color laser film (CLF) label for dental carpules. The label is designed for emissions-free variable marking of extremely narrow carpule surfaces, usually...
Articles
Why streamlining pharma supply chain is essential
For most pharmaceuticals executives, the prospect of the patent cliff is looming large in their thoughts. But an additional – and less obvious – challenge is also ready to derail future performance: that of excess inventory. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















